Recent advances of small-molecule c-Src inhibitors for potential therapeutic utilities

[Display omitted] Proto-oncogene tyrosine-protein kinase Src, also known as c-Src, belongs to the family of non-receptor tyrosine protein kinases (TKs) called Src kinases. It plays a crucial role in cell division, motility, adhesion, and survival in both normal cells and cancer cells by activating v...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic chemistry 2024-01, Vol.142, p.106934, Article 106934
Main Authors: Dang, Xia-Wen, Duan, Ji-Long, Ye, Emily, Mao, Nian-Dong, Bai, Ren-Ren, Zhou, Xinglu, Ye, Xiang-Yang
Format: Article
Language:English
Subjects:
C-Src
Small-molecule inhibitors
Therapeutic utilities
Tyrosine protein kinase (TKs)
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] Proto-oncogene tyrosine-protein kinase Src, also known as c-Src, belongs to the family of non-receptor tyrosine protein kinases (TKs) called Src kinases. It plays a crucial role in cell division, motility, adhesion, and survival in both normal cells and cancer cells by activating various signaling pathways mediated by multiple cytokines. Additionally, c-Src kinase has been implicated in osteoclasts and bone loss diseases mediated by inflammation and osteoporosis. In recent years, remarkable advancements have been achieved in the development of c-Src inhibitors, with several candidates progressing to the clinical stage. This review focuses on the research progress in several areas, including the mechanism of action, drug discovery, combination therapy, and clinical research. By presenting this information, we aim to provide researchers with convenient access to valuable insights and inspire new ideas to expedite future drug discovery programs.
ISSN:0045-2068
1090-2120
1090-2120
DOI:10.1016/j.bioorg.2023.106934